Showing posts with label post grant opposition. Show all posts
Showing posts with label post grant opposition. Show all posts

Sunday, December 26, 2010

Pre-grant and Post-grant Opposition by same parties - strategy and impact

There is an interesting angle to Application # IN/PCT/2000/00084/CHE. This Application was filed by Applicant on 22nd May 2000. A pre-grant opposition was filed on 22nd July 2005. A hearing for this pre-grant opposition was called for 12th July 2006.

The Opponent relied on following key grounds:
a) Applicant not entitled to claim priority since the priority documents come from period before India becoming member of PCT.
This argument was rejected by the Assistant Controller as he held that the International filing date of the Application is subsequent to India becoming a PCT member state.

b) Anticipation on grounds of Applicant’s own earlier filing US 5382600.
This argument too was rejected by the Controller as the current Application was a formulation / composition invention which was not disclosed at all in the ‘600 patent.

c) Some claims being vague/ indefinitive:
The Applicant traversed this ground by amending his claims- which amendment was found acceptable to the Controller.

d) Lack of utility:
This ground was rejected as the utility was clearly discussed.

e) Not an invention u/s 2(1)(j):
This ground was rejected.

f) Not patentable u/s 3(d) as combination of known substances:
Ground rejected as the Controller felt that the amended claims do not contradict the provisions Section 3(d) and Section 3(e) of the Patents Act.

g) Method of treatment not allowable:
Argument accepted and Method claim deleted.

In the pre-grant decision, while allowing a majority of the amended claims, the Controller also noted that ‘No appeal lies with the Appellate Board’.

The Application subsequently matured into patent IN211539 on 14/Dec/2007.

The pre-grant Opponent, being impacted by the grant, filed a post-grant opposition on almost same grounds and using same arguments. The Patentee, timely, filed its reply statement and evidence. Subsequently, the Opponent neither filed reply evidence nor attended the hearing. The Patentee attended the hearing.

The Opponent's attitude did not unnoticed by the Controller. While rejecting the post-grant opposition, the Controller wrote in his post-grant decision:

“…Post-grant opposition can be filed only by the 'interested person'. In the present opposition the Opponent claimed as an interested person for filing the post grant opposition, but not shown any interest thereafter. It appears that the interest of the opponent is to utilize the provisions of the Patents Act to present the opposition in this office but failed to continue with the proceedings. The purpose of the provision in the Act is defeated when the opponent failed to continue with the post-grant opposition proceedings.

This is not a 'pre-grant' opposition where any person can provide information to the controller to decide the fate of the case, but in the much restricted post-grant opposition the opponent should involve all further proceedings till the disposal of the opposition.

It appears that the Opponent is a 'person interested' only for the purpose of mere filing opposition, but not really a 'person interested' to oppose the patent. It is pertinent to mention that the Opponent is also opposed the grant of patent u/s 25(1) of the Act with similar grounds. This kind of approach of the Opponent unnecessarily put more workload on the patent administration, which also creates a suspicion on the Opponent for misusing the provisions of the Act. The Opponent should stop this sort of practice in future at least in the post-grant stage for smooth running of the administration.”

Interestingly, while the Controller was clearly not happy with the Opponent’s conduct, he did not pass an order for costs.

Tuesday, September 21, 2010

India: new decisions from the Patent Office

I hope you enjoyed reading the earlier decisions.

The IPO has recently posted some new decisions.

Particularly, this post grant decision for patent IN208718 is very interesting. Assistant Controller K. S. Hariram has penned decision worth reading. What I personally like is that he has put forth Opponent's views, Patentee's views and the Opposition Board's views against every ground raised, before giving his decision.

SpicyIP did a detailed post on the decision, here.

There are some other decisions as well.
a) 1169/MUMNP/2006 is decision u/s Section 15 involving phenantridine compounds. The Assistant Controller held that 'minor modifications such as an OH group at a different location in the same structural framework' does not involve inventive merit.

b) 416/MUMNP/2007 is also a decision under section 15 involving a process to make Atenolol. The Assistant Controller held that the process claims do not involve an inventive step.

c) IN212032 (coming from 657/MUMNP/2005) is an interesting decision. The Opponent filed a post-grant opposition u/s 25(2) and the Patentee filed a response. Post submission of additional evidence by Opponent, the Patentee decided to abandon the patent and communicated the same, to the Patent Office. The proceedings ended.

Monday, August 16, 2010

India: Recent patent decisions

I have written a couple of posts on decisions.

a) The IPO has uploaded 2 interesting post grant decisions. Details, here.

b) A decision related to the Cadila/ Glochem matter has been posted. Details, here.

c) The Delhi High Court has recently issued a great order on transparency at Patent Office. Details, here.

d) The post on revocation of Valganciclovir compound claims, here.

Wednesday, February 27, 2008

Sun opposes Risperidone related patent

Varun had posted this:

Mumbai-based Sun Pharmaceuticals Ltd. has filed a post-grant opposition in respect to Indian Patent No. 208191 issued to Janssen Pharmaceutica N.V. against the mail-box Application No. 188/CAL/1995. The opposition was filed on January 02, 2008 with the Mumbai Patent Office, which last year in July (dated July 20, 2007) published the grant of the ‘191 patent under section 43(2) of the Patents Act, 1970. The ‘191 patent relates to sustained-release micro-particle of risperidone.
After Varun put his post, the media also covered it: here.

My query:
What has got me thinking that if the patent application was filed at Kol patent office, then how was it granted by the BOM patent office?
Once an answer to that comes across, then we can understand the reason behind the Post grant Opposition being filed at the BOM patent office?